Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

An Open-Label, Global, Multicenter, Phase 1b/2 Study of KRT-232, a First-in-Class, Oral Small-Molecule Inhibitor of Murine Double Minute 2 (MDM2), Combined with Ruxolitinib in Patients Who Have Myelofibrosis and a Suboptimal Response to Ruxolitinib

John Mascarenhas, MD, Alessandro M. Vannucchi, MD, Adam J. Mead, MD PhD, Regina Garcia-Delgado, MD, Andrzej Pluta, MD, Hope Qamoos, CNP, Anne Uyei, MD, Damaj Gandhi Laurent, MD PhD, Haifa K Al-Ali

Blood (2020) 136 (Supplement 1): 44–45.

https://doi.org/10.1182/blood-2020-134262

Published: 2020

Journal Articles

Combined Bendamustine, Prednisone and Bortezomib (BPV) in Patients with Relapsed or Refractory Multiple Myeloma

Blood (2012) 120 (21): 1855.

https://doi.org/10.1182/blood.V120.21.1855.1855

Published: 2012

Journal Articles

Long Term Outcome After Low Dose TBI Based Conditioning Hematopoietic Stem Cell Transplantation (HSCT) From Related and Unrelated Donors for Older Patients with AML

Dietger Niederwieser, MD, Leo F Verdonck, Jan J Cornelissen, MD PhD, Michael Cross, PhD, Rainer Krahl, MD, Thoralf Lange, Vladan Vucinic, Georg Franke, MD, Haifa K. Al-Ali, MD, Gert Ossenkoppele, MD, PhD, Georg Maschmeyer, MD, Gottfried Doelken, MD, Mathias Freund, MD, Norma Peter, Marc Boogaerts, MD, PhD, Alois Gratwohl, MD, Harry C. Schouten, MD, PhD, Bob Lowenberg, MD, PhD

Blood (2011) 118 (21): 2030.

https://doi.org/10.1182/blood.V118.21.2030.2030

Published: 2011

Journal Articles

Impact of Bendamustine Pretreatment on Stem Cell Mobilization and Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Wolfram Pönisch, Julia Wiesler, Ina Wagner, Sabine Leiblein, Elvira Edel, Haifa K. Al-Ali, MD, Vladan Vucinic, Ute Hegenbart, MD, Christiane Heiß, Dietger Niederwieser, MD, Hartmut Goldschmidt, MD

Blood (2011) 118 (21): 1933.

https://doi.org/10.1182/blood.V118.21.1933.1933

Published: 2011

Journal Articles

Comparable Outcome After Single-Antigen Mismatched Versus Matched Unrelated Donor Hematopoietic Cell Transplantation,

Christian Pfrepper, Anja Büttner, Thoralf Lange, Haifa K. Al-Ali, MD, Christian Niederwieser, Gerhard Behre, MD, Michael Cross, PhD, Dietger Niederwieser, MD

Blood (2011) 118 (21): 4165.

https://doi.org/10.1182/blood.V118.21.4165.4165

Published: 2011

Journal Articles

Kinetics of Engraftment and Predictors of Outcome in Patients with Advanced Chronic Lymphocytic Leukaemia (CLL) After Treatment with Low Dose Total Body Irradiation (TBI) Followed by related or unrelated hematopoietic Stem Cell Transplantation

Karin Hebenstreit, Simona Iacobelli, Ann-Kathrin Eisfeld, MD, Christian Pfrepper, Thoralf Lange, MD, Rainer Krahl, MD, Haifa K. Al-Ali, MD, Cornelia Becker, MD, Wolfram Pönisch, Gerhard Behre, MD, Dietger Niederwieser, MD

Blood (2011) 118 (21): 4532.

https://doi.org/10.1182/blood.V118.21.4532.4532

Published: 2011

Journal Articles

Delayed Processing of Bone Marrow Samples Reveals a Prognostic Pattern of NME mRNA Expression in Cytogenetically Normal AML

Enrica Bach, PhD, Rainer Krahl, MD, Sabine Tschiedel, PhD, Thoralf Lange, Frank Schüler, MD, Haifa K. Al-Ali, MD, Thomas Büchner, MD, Gottfried Doelken, MD, Dietger Niederwieser, MD, Michael Cross, PhD

Blood (2011) 118 (21): 4904.

https://doi.org/10.1182/blood.V118.21.4904.4904

Published: 2011

Journal Articles

Allogeneic and Autologous Transplantation In Patients with Aggressive B- and T-Cell Lymphomas

Frank Schueler, MD, Madelaine Hoffmann, Christian Pfrepper, Said Daneschnejad, Thoralf Lange, MD, Wolfram Pönisch, Haifa K. Al-Ali, Dietger W Niederwieser, MD, Nadezda Basara, MD

Blood (2010) 116 (21): 3544.

https://doi.org/10.1182/blood.V116.21.3544.3544

Published: 2010

Journal Articles

Successful Mobilization of Peripheral Blood Stem Cells After Intensive Bendamustine Pre-Treatment In Patients with Multiple Myeloma

Wolfram Pönisch, Julia Wiesler, Sabine Leiblein, Elvira Edel, Haifa K. Al-Ali, Nadezda Basara, MD, Ute Hegenbart, Christiane Heiß, Dietger W Niederwieser, MD, Hartmut Goldschmidt

Blood (2010) 116 (21): 4439.

https://doi.org/10.1182/blood.V116.21.4439.4439

Published: 2010

Journal Articles

Combined Bendamustine, Prednisolone and Lenalidomide (RBP) In Refractory or Relapsed Multiple Myeloma. First Results of a Phase I Clinical Trial

Wolfram Pönisch, Simone Heyn, Ina Wagner, Martin Mohren, MD, Franz-Albert Hoffmann, Frank Schüler, Marion Schmalfeld, Haifa K. Al-Ali, Nadja Jäkel, Dietger W Niederwieser, MD

Blood (2010) 116 (21): 1971.

https://doi.org/10.1182/blood.V116.21.1971.1971

Published: 2010

Journal Articles

Monitoring of Incipient Haematological Relapse by CD34 + Donor Chimerism Determination in Patients with Acute Myelogenous Leukaemia and Myelodysplastic Syndrome after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Low Dose TBI-Based Conditioning Regimens.

Dietger W. Niederwieser, Claudia Nehring, Rainer Krahl, Cornelia Becker, Sabine Leiblein, Jeanett Edelmann, Wolf-Dieter Kortmann, Wolfram Poenisch, Thoralf Lange, Haifa K. Al-Ali

Blood (2007) 110 (11): 5033.

https://doi.org/10.1182/blood.V110.11.5033.5033

Published: 2007

Journal Articles

Outcome of Relapsed Philadelphia Chromosome Positive Chronic Myeloid Leukemia (Ph+ CML) after Allogeneic Hematopoietic Cell Transplantation (HCT).

Simone Heyn, MD, Rainer Krahl, PhD, Thoralf Lange, MD, Ann-Kathrin Eisfeld, MD, Dietger Niederwieser, MD, Haifa K. Al-Ali, MD

Blood (2007) 110 (11): 3230.

https://doi.org/10.1182/blood.V110.11.3230.3230

Published: 2007

Journal Articles

BCR-ABL Kinase Domain Mutations in the P-Loop and at Imatinib Contact Sites in CML Patients with Imatinib Resistance Are Associated with Higher Maximum Imatinib Doses.

Oliver Pelz-Ackermann, Michael W.N. Deininger, PhD, Michael Cross, PhD, Kathrin Wildenberger, Rainer Krahl, PhD, Song-Yau Wang, MD, Haifa K. Al-Ali, MD, Dietger W. Niederwieser, MD, Thoralf Lange, MD

Blood (2007) 110 (11): 2918.

https://doi.org/10.1182/blood.V110.11.2918.2918

Published: 2007

Journal Articles

Factors Influencing Relapse after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Haifa K. Al-Ali, MD, Claudia Nehring, MD, Rainer Krahl, PhD, Cornelia Becker, MD, Sabine Leiblein, PhD, Jeanett Edelmann, PhD, Wolfram Poenisch, MD, Thoralf Lange, MD, Dietger Niederwieser, MD

Blood (2007) 110 (11): 1654.

https://doi.org/10.1182/blood.V110.11.1654.1654

Published: 2007

Journal Articles

Donor CD34+ Cell Chimerism at Day 28 and Chronic Graft-Versus-Host Disease (GvHD) but Not High-Risk Cytogenetics Influence Outcome of Allogeneic Hematopoetic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Haifa K. Al-Ali, MD, Claudia Nehring, MD, Rainer Krahl, PhD, Cornelia Becker, MD, Sabine Leiblein, PhD, Jeanett Edelmann, MD, Wolfram Poenisch, MD, Thoralf Lange, MD, Dietger Niederwieser, MD

Blood (2006) 108 (11): 547.

https://doi.org/10.1182/blood.V108.11.547.547

Published: 2006

Journal Articles

5-Azacitidine Induces Hematologic Responses in a High Proportion of Patients with Acute Myeloid Leukaemia Refractory to or Not Eligible for Intensive Chemotherapy.

Haifa K. Al-Ali, MD, Sebastian Schwind, MD, Cornelia Becker, MD, Christl Mueller, Dietger Niederwieser, MD

Blood (2006) 108 (11): 1953.

https://doi.org/10.1182/blood.V108.11.1953.1953

Published: 2006

Journal Articles

First Results of a New PCR-Based Approach for a Sensitive and Quantitative Monitoring of BCR-ABL Kinase Domain Mutations in Patients with Chronic Myeloid Leukemia.

Oliver Pelz-Ackermann, Michael W. Deininger, Michael Cross, Ines Kovacs, Christine Guenther, Knuth Krohn, Song-Yau Wang, Haifa K. Al-Ali, Dietger W. Niederwieser, Thoralf Lange

Blood (2006) 108 (11): 2191.

https://doi.org/10.1182/blood.V108.11.2191.2191

Published: 2006

Journal Articles

Comparable Distribution of Minimal Residual Diesease between CD34 Positive Hematopoietic Progenitors, CD34 Negative Cells and Total White Cells in Patients with Chronic Myeloid Leukemia (CML) in Molecular Response.

Thoralf Lange, MD, Thomas Thielsen, Sabine Leiblein, PhD, Ruediger Alt, Guido Zschau, Ralf Burckhardt, Ines Kovacz, Haifa K. Al-Ali, MD, Christina Franke, Rainer Krahl, PhD, Dietger Niederwieser, MD, Michael W. Deininger, MD, PhD

Blood (2005) 106 (11): 1985.

https://doi.org/10.1182/blood.V106.11.1985.1985

Published: 2005

Journal Articles

Loss of Heterozygosity (LOH) for HumACTBP2 (SE33) Is Detected in Philadelphia (Ph)-Positive and Ph-Negative Hematopoietic Cells of Some Patients with Ph-Positive CML.

Haifa K. Al-Ali, MD, Jeanett Edelmann, MD, Sabine Leiblein, PhD, Christel Mueller, Evelin Hennig, Martina Bless, Christina Franke, Dietger W. Niederwieser, MD

Blood (2005) 106 (11): 3286.

https://doi.org/10.1182/blood.V106.11.3286.3286

Published: 2005

Journal Articles

Phlebotomy as an Effective Treatment for Iron Overload after Allogeneic Hematopoietic Cell Transplantation: Iron Depletion Kinetics Are Influenced by the Donor Hemochromatosis (HFE) Genotype.

Ann-Kathrin Eisfeld, Medical Student, Ralph Burkhardt, MD, Sabine Schroeder, MD, Rainer Krahl, PhD, Elvira Edel, MD, Christa Doering, Dietger Niederwieser, MD, Haifa K. Al-Ali, MD

Blood (2005) 106 (11): 3717.

https://doi.org/10.1182/blood.V106.11.3717.3717

Published: 2005

NARROW

An Open-Label, Global, Multicenter, Phase 1b/2 Study of KRT-232, a First-in-Class, Oral Small-Molecule Inhibitor of Murine Double Minute 2 (MDM2), Combined with Ruxolitinib in Patients Who Have Myelofibrosis and a Suboptimal Response to Ruxolitinib

Combined Bendamustine, Prednisone and Bortezomib (BPV) in Patients with Relapsed or Refractory Multiple Myeloma

Long Term Outcome After Low Dose TBI Based Conditioning Hematopoietic Stem Cell Transplantation (HSCT) From Related and Unrelated Donors for Older Patients with AML

Impact of Bendamustine Pretreatment on Stem Cell Mobilization and Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Comparable Outcome After Single-Antigen Mismatched Versus Matched Unrelated Donor Hematopoietic Cell Transplantation,

Kinetics of Engraftment and Predictors of Outcome in Patients with Advanced Chronic Lymphocytic Leukaemia (CLL) After Treatment with Low Dose Total Body Irradiation (TBI) Followed by related or unrelated hematopoietic Stem Cell Transplantation

Delayed Processing of Bone Marrow Samples Reveals a Prognostic Pattern of NME mRNA Expression in Cytogenetically Normal AML

Allogeneic and Autologous Transplantation In Patients with Aggressive B- and T-Cell Lymphomas

Successful Mobilization of Peripheral Blood Stem Cells After Intensive Bendamustine Pre-Treatment In Patients with Multiple Myeloma

Combined Bendamustine, Prednisolone and Lenalidomide (RBP) In Refractory or Relapsed Multiple Myeloma. First Results of a Phase I Clinical Trial

Monitoring of Incipient Haematological Relapse by CD34 + Donor Chimerism Determination in Patients with Acute Myelogenous Leukaemia and Myelodysplastic Syndrome after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Low Dose TBI-Based Conditioning Regimens.

Outcome of Relapsed Philadelphia Chromosome Positive Chronic Myeloid Leukemia (Ph+ CML) after Allogeneic Hematopoietic Cell Transplantation (HCT).

BCR-ABL Kinase Domain Mutations in the P-Loop and at Imatinib Contact Sites in CML Patients with Imatinib Resistance Are Associated with Higher Maximum Imatinib Doses.

Factors Influencing Relapse after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Donor CD34+ Cell Chimerism at Day 28 and Chronic Graft-Versus-Host Disease (GvHD) but Not High-Risk Cytogenetics Influence Outcome of Allogeneic Hematopoetic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

5-Azacitidine Induces Hematologic Responses in a High Proportion of Patients with Acute Myeloid Leukaemia Refractory to or Not Eligible for Intensive Chemotherapy.

First Results of a New PCR-Based Approach for a Sensitive and Quantitative Monitoring of BCR-ABL Kinase Domain Mutations in Patients with Chronic Myeloid Leukemia.

Comparable Distribution of Minimal Residual Diesease between CD34 Positive Hematopoietic Progenitors, CD34 Negative Cells and Total White Cells in Patients with Chronic Myeloid Leukemia (CML) in Molecular Response.

Loss of Heterozygosity (LOH) for HumACTBP2 (SE33) Is Detected in Philadelphia (Ph)-Positive and Ph-Negative Hematopoietic Cells of Some Patients with Ph-Positive CML.

Phlebotomy as an Effective Treatment for Iron Overload after Allogeneic Hematopoietic Cell Transplantation: Iron Depletion Kinetics Are Influenced by the Donor Hemochromatosis (HFE) Genotype.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only